buserelin has been researched along with dihydrotestosterone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (90.91) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costantini, A; De Bellis, A; Fiorelli, G; Longo, A; Natali, A; Serio, M | 1 |
| Irie, S; Matsumura, Y; Nagai, A; Nanba, K; Ohashi, T; Ohashi, Y; Ohmori, H; Tanahashi, T; Yamashita, Y | 1 |
| Crum, A; Handelsman, DJ; Peterson, M; Rajfer, J; Steiner, B; Swerdloff, RS | 1 |
| Jacobi, GH; Wenderoth, UK | 1 |
| Bélanger, A; Dubé, JY; Frenette, G; Labrie, F; Tremblay, RR; Tremblay, Y | 1 |
| Bélanger, A; Carmichael, R; Caron, S; Cusan, L; Labrie, F; Séguin, C | 1 |
| Labrie, F; Marchetti, B; Pelletier, G; Reeves, JJ | 1 |
| Faure, N; Fazekas, AT; Klioze, S; Koutsilieris, M; Lemay, A; Tolis, G; Yakabow, A | 1 |
| Belanger, A; Cusan, L; Dupont, A; Emond, JP; Fazekas, AT; Husson, JM; Laberge, JG; Labrie, F; Lefebvre, FA; Monfette, G; Raynaud, JP | 1 |
| Bélanger, A; Faure, N; Gourdeau, Y; Labrie, F; Laroche, B; Lemay, A; Robert, G | 1 |
| Baroncelli, GI; Bertelloni, S; Ferdeghini, M; Menchini-Fabris, F; Saggese, G | 1 |
11 other study(ies) available for buserelin and dihydrotestosterone
| Article | Year |
|---|---|
Epidermal growth factor receptors in human hyperplastic prostate tissue and their modulation by chronic treatment with a gonadotropin-releasing hormone analog.
Topics: Aged; Binding Sites; Buserelin; Dihydrotestosterone; Epidermal Growth Factor; ErbB Receptors; Goserelin; Humans; Male; Middle Aged; Models, Biological; Prostatic Hyperplasia; Testosterone | 1989 |
[Clinical and endocrinological studies of the luteinizing hormone-releasing hormone analogue therapy in prostatic cancer patients].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgens; Antineoplastic Agents; Buserelin; Dihydrotestosterone; Drug Evaluation; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms; Remission Induction; Testosterone | 1989 |
Comparison of the efficacy of subcutaneous and nasal spray buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancer.
Topics: Administration, Intranasal; Aged; Buserelin; Dihydrotestosterone; Drug Evaluation; Estradiol; Gonadal Steroid Hormones; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prospective Studies; Prostatic Neoplasms; Random Allocation; Testis; Testosterone | 1986 |
Long-term endocrine profiles of prostatic carcinoma patients under pernasal as well as intramuscular Gn-RH analogue treatment.
Topics: Administration, Intranasal; Buserelin; Dihydrotestosterone; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Male; Prostatic Neoplasms; Testosterone; Time Factors; Triptorelin Pamoate | 1985 |
Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Animals; Buserelin; Castration; Dihydrotestosterone; Dogs; Estrogens; Hydroxyprogesterones; Male; Progesterone; Prostatic Hyperplasia; Testis; Testosterone | 1984 |
Increased testicular 5 alpha-androstane-3 alpha, 17 beta-diol formation induced by treatment with [D-Ser (TBU) 6, des-Gly-NH2(10)] LHRH ethylamide in the rat.
Topics: 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstane-3,17-diol; Androstanols; Animals; Buserelin; Dihydrotestosterone; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Rats; Receptors, Cell Surface; Testis; Testosterone | 1980 |
Modulation of pituitary luteinizing hormone releasing hormone receptors by sex steroids and luteinizing hormone releasing hormone in the rat.
Topics: Animals; Buserelin; Dihydrotestosterone; Estradiol; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Pituitary Gland, Anterior; Progesterone; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, LHRH; Testosterone | 1982 |
Suppression of testicular steroidogenesis by the GnRH agonistic analogue Buserelin (HOE-766) in patients with prostatic cancer: studies in relation to dose and route of administration.
Topics: Aged; Androgens; Buserelin; Dihydrotestosterone; Gonadotropin-Releasing Hormone; Hormones; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testis; Testosterone | 1983 |
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogen.
Topics: Androgen Antagonists; Animals; Buserelin; Castration; Dihydrotestosterone; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Hormones; Humans; Imidazoles; Imidazolidines; Male; Prostate; Prostatic Neoplasms; Rats; Seminal Vesicles; Testosterone | 1983 |
Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men.
Topics: Administration, Intranasal; Aged; Buserelin; Dihydrotestosterone; Estradiol; Gonadotropin-Releasing Hormone; Humans; Hydroxyprogesterones; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testosterone; Time Factors | 1982 |
Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.
Topics: Adolescent; Body Height; Bone Density; Buserelin; Dihydrotestosterone; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Puberty, Precocious; Sperm Count; Sperm Motility; Testis; Testosterone; Triptorelin Pamoate | 2000 |